The Lichen planus therapeutics market comprises drugs that help treat symptoms of lichen planus, a common inflammatory skin rash. These drugs include corticosteroids, retinoids, immunomodulators and others. Lichen planus is a common skin rash affecting around 1-2% of the general population.

It occurs when the body's immune system attacks its own tissues causing itchy, purple-colored, scaly patches or bumps on the wrists, legs and trunk of the body. While the exact cause is still unknown, Lichen Planus Market is considered an autoimmune disorder. Treatment aims to reduce symptoms of itching, inflammation and pain.

The Global Lichen Planus Market is estimated to be valued at USD 150.1 million in 2024 and is expected to reach USD 251.2 million by 2031, growing at a compound annual growth rate (CAGR) of 7.6% from 2024 to 2031.

Key players operating in the lichen planus therapeutics market are Novartis, F. Hoffmann-La Roche Ltd, Sanofi, Pfizer Inc., GlaxoSmithKline plc.

The increasing prevalence of lichen planus disease globally is expected to drive the market growth during the forecast period. According to the National Organization for Rare Disorders, lichen planus prevalence rate is estimated to be 0.22-2.6% of the population.

Technological advancements are allowing researchers to better understand the pathophysiology of lichen planus and develop more effective and targeted treatment options. Companies are increasingly focusing on developing new drug formulations, combination therapies and biologics to treat lichen planus.

Market Trends
Increasing awareness - Various awareness campaigns by government and non-profit organizations regarding lichen planus causes, risk factors and available treatment options are helping people identify the condition early. This is expected to drive more patients to seek treatment.

Focus on combination therapies - Researchers are exploring the effectiveness of combining corticosteroids with immunomodulators and antibiotics to boost treatment outcomes. Combination therapies help improve medication adherence and manage disease progression more effectively.

Market Opportunities
High unmet needs in developing countries: Developing regions like Asia Pacific and Latin America have higher disease prevalence but lack adequate healthcare facilities and access to good dermatologists. This presents an opportunity for global players to tap new emerging markets.

Novel drug delivery systems: Developing novel formulations like topical gels, patches and prolonged release tablets can help improve medication compliance. This is an area attracting significant research investments from pharmaceutical companies.

Impact of COVID-19 on Lichen Planus Market Growth
The COVID-19 pandemic has severely impacted the growth of the lichen planus market. During the initial phase of lockdowns imposed worldwide, the market witnessed a steep decline owing to the shutdown of diagnostic labs and hospitals except for emergency services. This led to postponing of non-essential medical checkups and treatments for lichen planus. However, with the lifting of lockdowns and reopening of healthcare facilities, the market is gradually regaining lost momentum.

Telemedicine emerged as a major tool for dermatologists to examine and diagnose patients with lichen planus during lockdowns. Various awareness campaigns were launched online and on social media platforms to educate people about the condition and available treatment options. Pharmaceutical companies also scaled up production of topical corticosteroids and other oral medications used to manage lichen planus symptoms.

Going forward, the market is expected to grow steadily as more effective drugs are introduced. Advanced therapeutics utilizing novel drug delivery systems can potentially improve treatment outcomes. Increased health insurance coverage and supportive government policies would further aid market expansion. Nonetheless, the potential risk of subsequent COVID waves poses challenges. Maintaining strict safety protocols and prioritizing vaccine rollouts remain key to sustaining the recovering growth trajectory.

Geographical Concentration of Lichen Planus Market
In terms of value, the lichen planus market is concentrated highly in North America and Europe. This is attributed to rising awareness about lichen planus, established healthcare infrastructure, widespread diagnostic facilities and availability of advanced treatment options in these regions.

According to various surveys, nearly 35-40% of global market share is held by countries such as the United States, Germany, France and the United Kingdom. The large patient pools affected by lichen planus and high per capita healthcare expenditures provide lucrative opportunities for market players. Asia Pacific is also emerging as a major regional market, driven by increasing income levels, growing medical tourism and expanding healthcare spending in nations like China, India and Japan.

Fastest Growing Region in Lichen Planus Market
Asia Pacific is currently the fastest growing region in the global lichen planus market. Rapid economic development, rising awareness about skin disorders, growing aged population susceptible to lichen planus and increasing healthcare investments are fueling regional market demand.

Countries like India, China, Indonesia, Thailand and Philippines are witnessing a high prevalence rate of lichen planus cases. Significant improvements in diagnostic capabilities along with favorable government policies supporting healthcare infrastructure upgrades are boosting market expansion.

Additionally, increasing collaboration between local pharmaceutical firms and international vendors for novel drug development is positively impacting the Asia Pacific lichen planus market. Rising medical tourism, especially from Japan and Southeast Asian nations seeking affordable yet quality treatments, acts as a key growth driver. Overall, the Asia Pacific market is projected to sustain double-digit growth over the next five years.

Get more insights on: Lichen Planus Market

Get this Report in Japanese Language: 扁平苔癬マーケット

Get this Report in Korean Language: 리켄 플라누스 마켓      

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)